Related Experiment Video
Updated: Jul 7, 2026

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
Published on: October 31, 2012
Early Response to Therapeutic Plasma Exchange as a Prognostic Indicator in Pediatric Liver Transplant Recipients with
Ibrahim Bingol1, Tonguc Utku Yilmaz2, Ozge Umur1
1Department of Pediatric Intensive Care, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey.
Insights
Early response to therapeutic plasma exchange (TPE) within 72 hours significantly predicts survival in pediatric liver transplant recipients experiencing early allograft dysfunction (EAD). This finding offers a crucial prognostic tool for managing these high-risk patients.
Area of Science:
- Pediatric Hepatology
- Transplantation Immunology
- Critical Care Medicine
Background:
- Early allograft dysfunction (EAD) significantly increases morbidity and mortality post-pediatric liver transplantation.
- Limited pediatric-specific data exist on the efficacy of therapeutic plasma exchange (TPE) as supportive care for EAD.
- This study investigates the predictive value of early TPE response on survival in pediatric liver transplant recipients with EAD.
Purpose of the Study:
- To determine if early response to TPE predicts survival in pediatric liver transplant recipients with EAD.
- To identify potential early markers for predicting TPE response and patient outcomes.
- To provide evidence supporting the use of TPE in pediatric liver transplantation.
Main Methods:
- Retrospective analysis of 15 pediatric patients (0-18 years) with EAD post-living donor liver transplantation who received TPE (2015-2023).
- EAD diagnosed using Olthoff criteria; TPE response assessed within 72 hours using predefined criteria.
- Patients categorized into responders (n=9) and non-responders (n=6).
Main Results:
- Responders demonstrated significant improvements in total bilirubin, INR, AST, and ALT (p<0.004).
- In-hospital mortality was exclusively observed in non-responders (83.3% vs. 0%, p=0.001).
- Kaplan-Meier analysis showed significant survival divergence (100% vs. 16.7% at day 45, p=0.0005); lower pre-TPE albumin predicted non-response (p=0.013).
Conclusions:
- Early TPE response within 72 hours is a strong predictor of survival in pediatric EAD.
- TPE response can serve as a practical prognostic tool for guiding clinical management.
- Prospective multicenter studies are recommended to validate these findings.
Background:
Early allograft dysfunction (EAD) is a major determinant of morbidity and mortality after pediatric liver transplantation. Therapeutic plasma exchange (TPE) is increasingly used as supportive therapy, yet pediatric-specific data remain limited. We aimed to determine whether early response to TPE predicts survival in pediatric liver transplant recipients with EAD.
Methods:
In this retrospective study, 15 pediatric patients (0-18 years) who developed EAD after living donor liver transplantation and received TPE (2015-2023) were analyzed. EAD was defined by Olthoff criteria. Response was assessed within 72 h using predefined criteria. Patients were classified as responders (n = 9) or non-responders (n = 6).
Results:
Among 140 pediatric liver transplant recipients, 15 (10.7%) developed EAD. The median age was 13 months (IQR: 9.1-22.6), and 80% weighed ≤ 10 kg. Responders showed significant reductions in total bilirubin (17.0 to 9.0 mg/dL; p = 0.004), INR (3.0 to 1.5; p = 0.004), AST (2239 to 150 IU/L; p = 0.004), and ALT (2467 to 200 IU/L; p = 0.004); non-responders showed no meaningful improvement. In-hospital mortality occurred exclusively among non-responders (83.3% vs. 0%; p = 0.001). Kaplan-Meier analysis revealed significant survival divergence (100% vs. 16.7% at day 45; log-rank p = 0.0005). Pre-TPE albumin was significantly lower in non-responders (2.90 vs. 3.20 g/dL; p = 0.013), highlighting albumin as a potential early bedside screening parameter for identifying patients at higher risk of non-response. One-year overall survival was 66.7%.
Conclusions:
Early response to TPE within 72 h strongly discriminates survival in pediatric EAD and may serve as a practical prognostic tool. Prospective multicenter studies are warranted to validate these findings.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
